LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 178 filers reported holding LEGEND BIOTECH CORP in Q2 2024. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $884,028 | -22.4% | 19,960 | -1.0% | 0.04% | -21.3% |
| Q1 2024 | $1,138,806 | -7.4% | 20,163 | -1.4% | 0.05% | -7.8% |
| Q4 2023 | $1,229,875 | +91476.7% | 20,440 | +2.3% | 0.05% | -7.3% |
| Q3 2023 | $1,343 | -3.0% | 19,989 | -0.3% | 0.06% | -24.7% |
| Q2 2023 | $1,384 | +20.7% | 20,054 | -11.6% | 0.07% | +40.4% |
| Q1 2023 | $1,147 | +2.4% | 22,691 | +1.2% | 0.05% | +13.0% |
| Q4 2022 | $1,120 | -99.9% | 22,429 | -1.6% | 0.05% | -4.2% |
| Q3 2022 | $930,000 | -21.5% | 22,804 | +5.9% | 0.05% | +14.3% |
| Q2 2022 | $1,185,000 | +46.7% | 21,540 | -3.1% | 0.04% | +27.3% |
| Q1 2022 | $808,000 | -15.0% | 22,228 | +8.9% | 0.03% | +37.5% |
| Q4 2021 | $951,000 | +6692.9% | 20,409 | +7215.1% | 0.02% | – |
| Q3 2021 | $14,000 | +27.3% | 279 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | 0.0% | 279 | -27.0% | 0.00% | – |
| Q1 2021 | $11,000 | 0.0% | 382 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | – | 382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
| JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
| HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
| Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
| Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
| Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
| Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
| INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |